The company has issued voluntary recall of one batch of Metformin
extended release tablets (USP 500 mg) due to detection of NDMA
(N-nitrosodimethylamine), Marksans Pharma said in a regulatory filing.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/marksans-pharma-recalls-11279-bottles-of-diabetes-drug-due-to-cancer-causing-chemical/articleshow/76260387.cms
No comments:
Post a Comment